Sarepta Therapeutics, Inc.
SRPT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000873303
No open-market purchases or sales by Sarepta Therapeutics, Inc. insiders were filed in the last 90 days; 323 institutions reported holding it in 13F filings for Q2 2026, worth $1.93B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Sarepta Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 320
- −40 vs. Q2 2025
- Shares held
- 86.8M
- +4.96M (+6.1%) vs. Q2 2025
- Total value
- $1.67B
- +$273.7M (+19.5%) vs. Q2 2025
- New holders
- 65
- 109 more added
- Sold out
- 105
- 105 more reduced
3 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 323 | $1.93B |
| Q1 2026 | 345 | $2.24B |
| Q4 2025 | 348 | $2.01B |
| Q3 2025 | 320 | $1.67B |
| Q2 2025 | 363 | $1.42B |
| Q1 2025 | 431 | $5.56B |
| Q4 2024 | 466 | $10.7B |
| Q3 2024 | 459 | $10.8B |
| Q2 2024 | 485 | $14.0B |
| Q1 2024 | 415 | $10.8B |
| Q4 2023 | 396 | $7.92B |
| Q3 2023 | 395 | $10.1B |
| Q2 2023 | 405 | $9.38B |
| Q1 2023 | 427 | $11.2B |
| Q4 2022 | 413 | $10.2B |
| Q3 2022 | 376 | $8.65B |
| Q2 2022 | 333 | $5.50B |
| Q1 2022 | 328 | $5.71B |
| Q4 2021 | 344 | $6.48B |
| Q3 2021 | 308 | $6.08B |
| Q2 2021 | 332 | $5.04B |
| Q1 2021 | 367 | $4.97B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Sarepta Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Private Wealth Management Group, LLC | 0 | $0 | 0.00% | −219−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −108−100.0% | Sold out |
| NBT Bank N A | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Briaud Financial Planning, Inc | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Wolff Wiese Magana LLC | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Beacon Capital Management, LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Roxbury Financial LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Prestige Wealth Management Group LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Cape Investment Advisory, Inc. | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| CarsonAllaria Wealth Management, Ltd. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Webster Bank, N. A. | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| CVA Family Office, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Park Place Capital Corp | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| TFC Financial Management | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Traub Capital Management LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| HFM Investment Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Roble, Belko & Company, Inc | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Hemington Wealth Management | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Norges Bank | – | – | – | – | Not filed |
| E Fund Management Co., Ltd. | – | – | – | – | Not filed |
| First Horizon Advisors, Inc. | – | – | – | – | Not filed |